zintick

Myriad Genetics MYGN

Myriad Genetics Inc · Nasdaq · In Vitro & In Vivo Diagnostic Substances

$6.63+5.41%close on Oct. 28, 2026 · volume 2.5M · Yahoo Finance

Price, last 47 sessions

$4.00$5.00$6.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $6.63 · low $3.05 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 15 →
  • SCHEDULE 13G/AOct. 27, 2026, 4:09 p.m. ETView on SEC.gov
  • 8-KOct. 20, 2026, 8:36 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedMyriad Genetics to sell prenatal health testing business to Labcorp for $210 million cash plus inventory

  • 8-KOct. 9, 2026, 4:16 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Financial statements and exhibits

  • 4Sept. 22, 2026, 4:12 p.m. ETView on SEC.gov
  • 4Sept. 18, 2026, 4:17 p.m. ETView on SEC.gov
  • 4Sept. 17, 2026, 4:34 p.m. ETView on SEC.gov
  • 8-KSept. 16, 2026, 8 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits

  • 4Sept. 8, 2026, 4:18 p.m. ETView on SEC.gov